Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
TRUSTEE'S OF THE UNIVERSITY OF PENNSYLVANIA v. ST. JUDE CHILDREN'S RESEARCH HOSPITAL
Case Number:
2:13-cv-01502
Court:
Nature of Suit:
Judge:
Firms
- Arnold & Porter
- Foley & Lardner
- Fox Rothschild
- Gibbons PC
- Hangley Aronchick
- Irell & Manella
- Jones Day
- Morgan Lewis
Companies
Sectors & Industries:
-
April 06, 2015
Novartis To Pay $12.3M, Royalties To End IP Row With Juno
Novartis Pharmaceuticals Corp. will pay $12.25 million and royalties to Juno Therapeutics Inc. to settle a three-year-old patent dispute over cancer immunotherapy drugs between a university and a hospital with which they struck licensing deals, the parties said on Monday.
-
March 25, 2013
UPenn Says St. Jude Cancer Therapy Patent Is Invalid
The University of Pennsylvania on Friday sought to declare invalid a patent held by St. Jude Children's Hospital related to a "groundbreaking" new immunotherapy treatment for cancer that is at the center of a pitched legal battle between the former collaborators.